Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor γ Activity: A Combined Virtual Screening and Biological Assay Approach-Reference-Cited by-同舟云学术

Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor γ Activity: A Combined Virtual Screening and Biological Assay Approach

Published:2006-11-02 Issue:2 Volume:71 Page:398-406
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Scarsi Marco,Podvinec Michael,Roth Adrian,Hug Hubert,Kersten Sander,Albrecht Hugo,Schwede Torsten,Meyer Urs A.,Rücker Christoph

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference55 articles.

1. Mitiglinide

2. Anonymous (2006) Glurenorm, summary of product characteristics (SPC) from the eMC. http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc. asp?DocumentID=6950.

3. [[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents

4. Muraglitazar: An investigational agent for the treatment of type 2 diabetes and associated dyslipidemia

5. Structure of the PPARα and -γ Ligand Binding Domain in Complex with AZ 242; Ligand Selectivity and Agonist Activation in the PPAR Family

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation;Molecular Metabolism;2024-07

2. Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies;PLOS ONE;2023-08-24

3. Antidiabetic agents: Do they hit the right targets?;Frigid Zone Medicine;2022-12-01

4. Discovery of potent HDAC2 inhibitors based on virtual screening in combination with drug repurposing;Journal of Molecular Structure;2022-01

5. RNA sequencing reveals niche gene expression effects of beta-hydroxybutyrate in primary myotubes;Life Science Alliance;2021-08-18